TrialInternational journal of radiation oncology, biology, physics2020

Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424.

Barbara J Fisher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.